Back to Research Hub
ANI Pharmaceuticals, Inc.
ANIP
$72.45-0.61 (-0.83%)
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products.
StreetsValue research for ANI Pharmaceuticals, Inc. (ANIP)
Members get the full report for ANI Pharmaceuticals, Inc.: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.